{"id":2952,"date":"2026-03-24T15:31:00","date_gmt":"2026-03-24T15:31:00","guid":{"rendered":"https:\/\/americanvoiceofhealth.com\/index.php\/2026\/03\/24\/federal-drug-price-reforms-are-working-study-says\/"},"modified":"2026-03-24T15:31:00","modified_gmt":"2026-03-24T15:31:00","slug":"federal-drug-price-reforms-are-working-study-says","status":"publish","type":"post","link":"https:\/\/americanvoiceofhealth.com\/index.php\/2026\/03\/24\/federal-drug-price-reforms-are-working-study-says\/","title":{"rendered":"Federal drug price reforms are working, study says"},"content":{"rendered":"<header class=\"wp-block-harvard-gazette-article-header alignfull article-header is-style-classic has-colored-heading has-media-on-the-left\">\n<figure class=\"wp-block-image\"><\/figure>\n<div class=\"article-header__content\">\n\t\t\t<a class=\"article-header__category\" href=\"https:\/\/news.harvard.edu\/gazette\/section\/health\/\"><br \/>\n\t\t\tHealth\t\t<\/a><\/p>\n<h1 class=\"article-header__title wp-block-heading \">\n\t\tFederal drug price reforms are working, study says\t<\/h1>\n<p class=\"article-header__subheading wp-block-heading\">\n\t\t\tMedicare beneficiaries skipping fewer medications due to cost\t\t<\/p>\n<div class=\"article-header__meta\">\n<div class=\"wp-block-post-author\">\n<address class=\"wp-block-post-author__content\">\n<p class=\"author wp-block-post-author__name\">\n\t\tBeth Israel Deaconess Medical Center Communications\t<\/p>\n<\/p><\/address>\n<\/p><\/div>\n<p>\t\t<time class=\"article-header__date\" datetime=\"2026-03-13\"><br \/>\n\t\t\tMarch 13, 2026\t\t<\/time><\/p>\n<p>\t\t<span class=\"article-header__reading-time\"><br \/>\n\t\t\t4 min read\t\t<\/span>\n\t<\/div>\n<\/p><\/div>\n<\/header>\n<div class=\"wp-block-group alignwide has-global-padding is-content-justification-right is-layout-constrained wp-container-core-group-is-layout-f1f2ed93 wp-block-group-is-layout-constrained\">\n<p>More than one in four American adults struggle to afford their prescription medications. Those who can\u2019t are left with grim choices \u2014 skipping doses, cutting pills in half, or abandoning prescriptions entirely.<\/p>\n<p>New research from Richard A. and Susan F. Smith Center for Outcomes Research at Harvard-affiliated Beth Israel Deaconess Medical Center offers early evidence that federal drug pricing reforms intended to help are beginning to do just that.<\/p>\n<p>Published in JAMA Internal Medicine, the <a href=\"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/article-abstract\/2846009\">study<\/a> found that Medicare beneficiaries were less likely to report skipping, rationing, or foregoing medications due to cost after the Inflation Reduction Act\u2019s prescription drug cost-cutting provisions took effect Jan. 1, 2024. The improvement was greatest among those managing multiple chronic conditions.<\/p>\n<p>\u201cFor too long, Medicare patients have been forced to ration important medications because of cost. Our findings are an early signal that the Inflation Reduction Act is changing that \u2014 and the patients benefiting most are exactly those who need it most,\u201d said the study\u2019s senior author, Rishi K. Wadhera, associate director and section head of health policy at the Smith Center for Outcomes Research and an associate professor at Harvard Medical School.<\/p>\n<p>The act\u2019s 2024 provisions targeted two groups most burdened by drug costs. For Medicare beneficiaries with high medication spending, the law eliminated the 5 percent co-insurance requirement for catastrophic coverage, effectively capping annual out-of-pocket costs at approximately $3,300 per year. For lower-income enrollees who had been receiving only partial assistance, it expanded access to full subsidies, significantly reducing what they pay for their medications.<\/p>\n<p>To assess the real-world impact of these changes, researchers used a quasi-experimental difference-in-differences design, drawing on data from the National Health Interview Survey, an annual survey of more than 27,000 U.S. adults conducted by the Centers for Disease Control and Prevention. Wadhera and colleagues compared Medicare Part D beneficiaries between the ages of 62 and 67 to a similar group of privately insured adults who were not subject to the act\u2019s provisions.<\/p>\n<p>They found that Medicare beneficiaries experienced a 4.9 percentage point reduction in cost-related medication nonadherence relative to their privately insured counterparts. Specifically, fewer patients reported skipping doses, reducing doses, delaying prescription fills, or foregoing medications because of cost. The finding held up across multiple sensitivity analyses, including after adjusting for race, ethnicity, income, and educational attainment, and when compared to a different comparison group (dually-enrolled beneficiaries).<\/p>\n<div class=\"wp-block-harvard-gazette-supporting-content alignleft supporting-content\" id=\"supporting-content-df26ac64-05e1-4280-b2f8-3d79d662363c\">\n<div class=\"wp-block-harvard-gazette-harvard-quote harvard-quote is-style-colored\">\n<blockquote class=\"wp-block-quote\">\n<p>The effect was particularly pronounced among beneficiaries managing two or more chronic conditions who saw a 7.8 percentage point reduction in cost-related nonadherence.<\/p>\n<\/blockquote>\n<\/div>\n<\/div>\n<p>The effect was particularly pronounced among beneficiaries managing two or more chronic conditions \u2014 including hypertension, diabetes, heart disease, and cancer \u2014 who saw a 7.8 percentage point reduction in cost-related nonadherence. Compare that to privately insured adults, not covered by the act\u2019s provisions, for whom medication nonadherence rose more than 2 percentage points during the same period. As of June 30, 2024, 1.5 million Medicare beneficiaries had saved close to $1 billion from the act\u2019s elimination of the catastrophic coverage co-insurance requirement alone.<\/p>\n<p>\u201cWhen someone with diabetes or heart disease stops taking their medications due to cost, the consequences can be severe. Our data suggest that the [Inflation Reduction Act\u2019s] reforms are helping the highest-risk patients stay on the medications they need,\u201d said lead author of the study, Lucas Marinacci, a faculty physician investigator at the Richard A. and Susan F. Smith Center for Outcomes Research, general cardiologist at BIDMC, and instructor at Harvard Medical School.<\/p>\n<p>While the act\u2019s drug provisions are helping Medicare beneficiaries stay on their medications, they are not yet making a dent in their overall health care costs. The study found neither a corresponding improvement in Medicare beneficiaries\u2019 ability to pay medical bills nor a decrease in their anxiety about future health care costs.<\/p>\n<hr class=\"wp-block-separator has-alpha-channel-opacity is-style-narrow-single-line\" \/>\n<p>The study was supported in part by the National Institutes of Health.<\/p>\n<\/div>\n\n","protected":false},"excerpt":{"rendered":"<p>Health Federal drug price reforms are working, study says Medicare beneficiaries skipping fewer medications due to cost Beth Israel Deaconess Medical Center Communications March 13, 2026 4 min read More than one in four American adults struggle to afford their prescription medications. Those who can\u2019t are left with grim choices \u2014 skipping doses, cutting pills &#8230;<\/p>\n","protected":false},"author":1,"featured_media":2953,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"loftocean_post_primary_category":0,"loftocean_post_format_gallery":"","loftocean_post_format_gallery_ids":"","loftocean_post_format_gallery_urls":"","loftocean_post_format_video_id":0,"loftocean_post_format_video_url":"","loftocean_post_format_video_type":"","loftocean_post_format_video":"","loftocean_post_format_audio_type":"","loftocean_post_format_audio_url":"","loftocean_post_format_audio_id":0,"loftocean_post_format_audio":"","loftocean-featured-post":"","loftocean-like-count":0,"loftocean-view-count":54,"tinysalt_single_post_intro_label":"","tinysalt_single_post_intro_description":"","tinysalt_hide_post_featured_image":"","tinysalt_post_featured_media_position":"","tinysalt_single_site_header_source":"","tinysalt_single_custom_site_header":"0","tinysalt_single_custom_sticky_site_header":"0","tinysalt_single_custom_sticky_site_header_style":"sticky-scroll-up","tinysalt_single_site_footer_source":"","tinysalt_single_custom_site_footer":"0","footnotes":""},"categories":[37],"tags":[],"class_list":["post-2952","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-staying-healthy"],"_links":{"self":[{"href":"https:\/\/americanvoiceofhealth.com\/index.php\/wp-json\/wp\/v2\/posts\/2952","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/americanvoiceofhealth.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/americanvoiceofhealth.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/americanvoiceofhealth.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/americanvoiceofhealth.com\/index.php\/wp-json\/wp\/v2\/comments?post=2952"}],"version-history":[{"count":0,"href":"https:\/\/americanvoiceofhealth.com\/index.php\/wp-json\/wp\/v2\/posts\/2952\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/americanvoiceofhealth.com\/index.php\/wp-json\/wp\/v2\/media\/2953"}],"wp:attachment":[{"href":"https:\/\/americanvoiceofhealth.com\/index.php\/wp-json\/wp\/v2\/media?parent=2952"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/americanvoiceofhealth.com\/index.php\/wp-json\/wp\/v2\/categories?post=2952"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/americanvoiceofhealth.com\/index.php\/wp-json\/wp\/v2\/tags?post=2952"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}